EMEA (Europe, Middle East and Africa) Female Contraception Drug Market Report 2018

January 2018 | 103 pages | ID: E3C192D1529EN
QYResearch

Abstracts

In this report, the EMEA Female Contraception Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Female Contraception Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Female Contraception Drug market competition by top manufacturers/players, with Female Contraception Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Addex Therapeutics Ltd
• Agile Therapeutics Inc
• Bayer AG
• Evofem Inc
• Hervana Ltd
• Mithra Pharmaceuticals SA
• Orbis Biosciences Inc
• Teva Pharmaceutical Industries Ltd
• Viramal Ltd

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• AG-890
• Amphora
• BAY-1007626
• Drospirenone
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Clinic
• Hospital
• Homecare

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Female Contraception Drug Market Report 2017

1 FEMALE CONTRACEPTION DRUG OVERVIEW

1.1 Product Overview and Scope of Female Contraception Drug
1.2 Classification of Female Contraception Drug
  1.2.1 EMEA Female Contraception Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Female Contraception Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 AG-890
  1.2.4 Amphora
  1.2.5 BAY-1007626
  1.2.6 Drospirenone
  1.2.7 Others
1.3 EMEA Female Contraception Drug Market by Application/End Users
  1.3.1 EMEA Female Contraception Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Homecare
1.4 EMEA Female Contraception Drug Market by Region
  1.4.1 EMEA Female Contraception Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Female Contraception Drug (2012-2022)
  1.5.1 EMEA Female Contraception Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Female Contraception Drug Revenue and Growth Rate (2012-2022)

2 EMEA FEMALE CONTRACEPTION DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Female Contraception Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Female Contraception Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Female Contraception Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Female Contraception Drug Sale Price by Players (2012-2017)
2.2 EMEA Female Contraception Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Female Contraception Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Female Contraception Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Female Contraception Drug Sale Price by Type (2012-2017)
2.3 EMEA Female Contraception Drug (Volume) by Application
2.4 EMEA Female Contraception Drug (Volume and Value) by Region
  2.4.1 EMEA Female Contraception Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Female Contraception Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Female Contraception Drug Sales Price by Region (2012-2017)

3 EUROPE FEMALE CONTRACEPTION DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Female Contraception Drug Sales and Value (2012-2017)
  3.1.1 Europe Female Contraception Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Female Contraception Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Female Contraception Drug Sales and Market Share by Type
3.3 Europe Female Contraception Drug Sales and Market Share by Application
3.4 Europe Female Contraception Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Female Contraception Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Female Contraception Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Female Contraception Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Female Contraception Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Female Contraception Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Female Contraception Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Female Contraception Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Female Contraception Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST FEMALE CONTRACEPTION DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Female Contraception Drug Sales and Value (2012-2017)
  4.1.1 Middle East Female Contraception Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Female Contraception Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Female Contraception Drug Sales and Market Share by Type
4.3 Middle East Female Contraception Drug Sales and Market Share by Application
4.4 Middle East Female Contraception Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Female Contraception Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Female Contraception Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Female Contraception Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Female Contraception Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Female Contraception Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Female Contraception Drug Sales and Growth Rate (2012-2017)

5 AFRICA FEMALE CONTRACEPTION DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Female Contraception Drug Sales and Value (2012-2017)
  5.1.1 Africa Female Contraception Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Female Contraception Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Female Contraception Drug Sales and Market Share by Type
5.3 Africa Female Contraception Drug Sales and Market Share by Application
5.4 Africa Female Contraception Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Female Contraception Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Female Contraception Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Female Contraception Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Female Contraception Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Female Contraception Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Female Contraception Drug Sales and Growth Rate (2012-2017)

6 EMEA FEMALE CONTRACEPTION DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Addex Therapeutics Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Female Contraception Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Agile Therapeutics Inc
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Female Contraception Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Bayer AG
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Female Contraception Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Bayer AG Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Evofem Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Female Contraception Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Evofem Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Hervana Ltd
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Female Contraception Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Hervana Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Mithra Pharmaceuticals SA
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Female Contraception Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Orbis Biosciences Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Female Contraception Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Teva Pharmaceutical Industries Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Female Contraception Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Viramal Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Female Contraception Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Viramal Ltd Female Contraception Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 FEMALE CONTRACEPTION DRUG MANUFACTURING COST ANALYSIS

7.1 Female Contraception Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Female Contraception Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Female Contraception Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA FEMALE CONTRACEPTION DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Female Contraception Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Female Contraception Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Female Contraception Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Female Contraception Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Female Contraception Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Female Contraception Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Female Contraception Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Female Contraception Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Female Contraception Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Female Contraception Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Female Contraception Drug
Figure EMEA Female Contraception Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Female Contraception Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure AG-890 Product Picture
Figure Amphora Product Picture
Figure BAY-1007626 Product Picture
Figure Drospirenone Product Picture
Figure Others Product Picture
Figure EMEA Female Contraception Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Female Contraception Drug by Application in 2016
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure EMEA Female Contraception Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Female Contraception Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Female Contraception Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Female Contraception Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Female Contraception Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Female Contraception Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Female Contraception Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Female Contraception Drug Sales Share by Players (2012-2017)
Figure 2016 Female Contraception Drug Sales Share by Players
Figure 2017 Female Contraception Drug Sales Share by Players
Figure EMEA Female Contraception Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Female Contraception Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Female Contraception Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Female Contraception Drug Revenue Share by Players
Table 2017 EMEA Female Contraception Drug Revenue Share by Players
Table EMEA Female Contraception Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Female Contraception Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Female Contraception Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Female Contraception Drug by Type (2012-2017)
Figure EMEA Female Contraception Drug Sales Market Share by Type (2012-2017)
Table EMEA Female Contraception Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Female Contraception Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Type in 2016
Table EMEA Female Contraception Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Female Contraception Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Female Contraception Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Female Contraception Drug by Application (2012-2017)
Figure EMEA Female Contraception Drug Sales Market Share by Application in 2016
Table EMEA Female Contraception Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Female Contraception Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Female Contraception Drug by Region (2012-2017)
Figure EMEA Female Contraception Drug Sales Market Share in 2016
Table EMEA Female Contraception Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Female Contraception Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Female Contraception Drug by Region (2012-2017)
Figure EMEA Female Contraception Drug Revenue Market Share Regions in 2016
Table EMEA Female Contraception Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Female Contraception Drug Revenue and Growth Rate (2012-2017)
Table Europe Female Contraception Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Female Contraception Drug Market Share by Type (2012-2017)
Figure Europe Female Contraception Drug Market Share by Type in 2016
Table Europe Female Contraception Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Female Contraception Drug Market Share by Application (2012-2017)
Figure Europe Female Contraception Drug Market Share by Application in 2016
Table Europe Female Contraception Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Female Contraception Drug Sales Market Share by Countries (2012-2017)
Figure Europe Female Contraception Drug Sales Market Share by Countries (2012-2017)
Figure Europe Female Contraception Drug Sales Market Share by Countries in 2016
Table Europe Female Contraception Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Female Contraception Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Female Contraception Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Female Contraception Drug Revenue Market Share by Countries in 2016
Figure Germany Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Female Contraception Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Female Contraception Drug Market Share by Type (2012-2017)
Figure Middle East Female Contraception Drug Market Share by Type (2012-2017)
Table Middle East Female Contraception Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Female Contraception Drug Market Share by Applications (2012-2017)
Figure Middle East Female Contraception Drug Sales Market Share by Application in 2016
Table Middle East Female Contraception Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Female Contraception Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Female Contraception Drug Sales Volume Market Share by Countries in 2016
Table Middle East Female Contraception Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Female Contraception Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Female Contraception Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Female Contraception Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Female Contraception Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Female Contraception Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Female Contraception Drug Sales Market Share by Type (2012-2017)
Figure Africa Female Contraception Drug Sales Market Share by Type (2012-2017)
Figure Africa Female Contraception Drug Sales Market Share by Type in 2016
Table Africa Female Contraception Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Female Contraception Drug Sales Market Share by Application (2012-2017)
Figure Africa Female Contraception Drug Sales Market Share by Application (2012-2017)
Table Africa Female Contraception Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Female Contraception Drug Sales Market Share by Countries (2012-2017)
Figure Africa Female Contraception Drug Sales Market Share by Countries (2012-2017)
Figure Africa Female Contraception Drug Sales Market Share by Countries in 2016
Table Africa Female Contraception Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Female Contraception Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Female Contraception Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Female Contraception Drug Revenue Market Share by Countries in 2016
Figure South Africa Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Addex Therapeutics Ltd Female Contraception Drug Basic Information List
Table Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Addex Therapeutics Ltd Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Agile Therapeutics Inc Female Contraception Drug Basic Information List
Table Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Agile Therapeutics Inc Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Female Contraception Drug Basic Information List
Table Bayer AG Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer AG Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Evofem Inc Female Contraception Drug Basic Information List
Table Evofem Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Evofem Inc Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Evofem Inc Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Evofem Inc Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Hervana Ltd Female Contraception Drug Basic Information List
Table Hervana Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hervana Ltd Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Hervana Ltd Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Hervana Ltd Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Mithra Pharmaceuticals SA Female Contraception Drug Basic Information List
Table Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Orbis Biosciences Inc Female Contraception Drug Basic Information List
Table Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Orbis Biosciences Inc Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Basic Information List
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Viramal Ltd Female Contraception Drug Basic Information List
Table Viramal Ltd Female Contraception Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Viramal Ltd Female Contraception Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Viramal Ltd Female Contraception Drug Sales Market Share in EMEA (2012-2017)
Figure Viramal Ltd Female Contraception Drug Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Female Contraception Drug
Figure Manufacturing Process Analysis of Female Contraception Drug
Figure Female Contraception Drug Industrial Chain Analysis
Table Raw Materials Sources of Female Contraception Drug Major Manufacturers in 2016
Table Major Buyers of Female Contraception Drug
Table Distributors/Traders List
Figure EMEA Female Contraception Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Female Contraception Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Female Contraception Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Female Contraception Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Female Contraception Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Female Contraception Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Female Contraception Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Female Contraception Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Female Contraception Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Female Contraception Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Female Contraception Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Female Contraception Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Female Contraception Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Female Contraception Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Female Contraception Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Female Contraception Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Female Contraception Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Female Contraception Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Female Contraception Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Female Contraception Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Female Contraception Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Female Contraception Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Female Contraception Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources